What's New
AFTD News
AFTD Grant Recipient Discusses Gene Therapy for FTD-GRN on Canadian TV
In an interview with the Canadian Broadcasting Corporation, Dr. Simon Ducharme of McGill University in Montreal discussed…
One-Night Performance of Acclaimed Play UnRavelled Examines Art, Science, and Dementia
AFTD staff and Board members attended a performance of the play UnRavelled at the San Francisco Conservatory…
AFTD News: Spring 2023, Vol. 20, Issue 1
In this issue: Bruce Willis Announcement Brings FTD Awareness to Millions Worldwide; L.A. Rams Coach Dons AFTD…
AFTD News: Fall 2022, Vol. 19, Issue 3
In this issue: From Hope to Action: AFTD Commits to Bold 2022-2025 Strategic Plan; AFTD Updates Several…
AFTD News: Summer 2022, Vol. 19, Issue 2
In this issue: First Annual Holloway Summit Focuses on Digital Assessment Tools for FTD; 1,200+ Join AFTD’s…
AFTD News: Spring 2022, Vol. 19, Issue 1
In this issue: 2021 FTSG Meeting Sees Development of FTD Treatments Gaining Ground; Remembering John Q. Trojanowski,…
AFTD News: Fall 2021, Vol. 18, Issue 3
In this issue: AFTD Publishes Landmark Report to Bring Federal Attention to FTD; New AFTD Resource Offers…
AFTD News: Summer 2021, Vol. 18, Issue 2
In this issue: AFTD’s 2021 Education Conference Offers Resources, Support, Hope; ALLFTD Study Recruiting Participants to Help…
AFTD News: Spring 2021, Vol. 18, Issue 1
In this issue: Newhouse and Holloway Gifts to Advance AFTD’s Mission; FTD Disorders Registry Announces Its First…
AFTD News: Fall 2020, Vol. 17, Issue 3
In this issue: AFTD to Host Patient-Focused Drug Development Meeting with FDA; A Week of Awareness…; Spotlight…
By Category
Our Newsletters
Sign Up with AFTD
Stay on top of the latest FTD news and AFTD events.
English 
Spanish (Mexico) 
French 
German 
Swedish 
Portuguese 
Italian 
Dutch 
Danish 
Polish 
Spanish (Spain)